Vikram Karnani
CIK: 0001699488
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
Award(A)Direct79.3K shares- - Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
Award(A)Direct32.5K shares- - Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
Tax Payment(F)Direct11.3K shares at avg. $46.75$528K - Dec 22, 2025DYN
Dyne Therapeutics, Inc.
Award(A)DirectStock option (right to buy)
59.7K shares- - Nov 12, 2025COLL
COLLEGIUM PHARMACEUTICAL, INC
Tax Payment(F)Direct9K shares at avg. $47.35$425K - Nov 12, 2024COLL
COLLEGIUM PHARMACEUTICAL, INC
Award(A)Direct106K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award(A) | 79,264 | - | $0 | Direct |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award(A) | 32,531 | - | $0 | Direct |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Tax Payment(F) | 11,296 | $46.75 | $528,088 | Direct |
| Dec 22, 2025 | DYN Dyne Therapeutics, Inc. | Award(A) Stock option (right to buy) | 59,665 | - | - | Direct |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | Tax Payment(F) | 8,983 | $47.35 | $425,345 | Direct |
| Nov 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award(A) | 105,972 | - | $0 | Direct |
1-6 of 6 transactions
About Karnani Vikram
Karnani Vikram (SEC CIK 0001699488) files insider reports with the SEC as President and CEO of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Director of Dyne Therapeutics, Inc. (DYN).
Signal8 holds 6 ownership filings by Karnani Vikram (2 Form 3, 4 Form 4), filed between Nov 14, 2024 and Feb 12, 2026. Those filings report 6 transactions, from Nov 12, 2024 to Feb 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Karnani Vikram's filings is in STOUGHTON, MA.
Recent filings by Karnani Vikram
- Feb 10, 2026: Grants or awards of COLL shares (2 lines, Form 4, code A).
- Feb 10, 2026: Tax withholding of COLL shares (Form 4, code F).
- Dec 22, 2025: Grant or award of DYN derivative securities (Form 4, code A).
- Nov 12, 2025: Tax withholding of COLL shares (Form 4, code F).
- Nov 12, 2024: Grant or award of COLL shares (Form 4, code A).
Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- SANTINI GINO, Director
- Freund John Gordon, Director
- Lurker Nancy, Director
- Paya Carlos V, Director
- Glancy Donovan Michael, Director
- BOHLIN GAREN G, Director